|
MechanismEpCAM inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Chengdu Yimoufeng Biotechnology Co., Ltd.
0 Patents (Medical) associated with Chengdu Yimoufeng Biotechnology Co., Ltd.
100 Deals associated with Chengdu Yimoufeng Biotechnology Co., Ltd.
100 Translational Medicine associated with Chengdu Yimoufeng Biotechnology Co., Ltd.